Carole Bamford, wife of billionaire Lord Bamford, has demonstrated she doesn't mince her words either - as was evident when the Duchess of Sussex launched her brand As Ever yesterday.

Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldn't top the benchmark S&P 500 ...

On Alex Cooper's new episode of 'Call Her Daddy,' Lauren Graham reveals what of her personal clothes was used for Lorelai ...

Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that ...

Hims & Hers Health's HIMS short percent of float has risen 5.58% since its last report. The company recently reported that it has 54.73 million shares sold short, which is 28.0% of all regular shares ...

Investors worry patients won’t make that price leap and that Hims, which has built its business on affordable healthcare, ...

The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

Hims & Hers (HIMS) is down -5.0%, or -$1.55 to $29.50.Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top ...

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...